Neurometrix Company Profile (NASDAQ:NURO)

About Neurometrix (NASDAQ:NURO)

Neurometrix logoNeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NURO
  • CUSIP: N/A
  • Web: www.neurometrix.com
Capitalization:
  • Market Cap: $4.37 million
  • Outstanding Shares: 1,268,000
Average Prices:
  • 50 Day Moving Avg: $1.59
  • 200 Day Moving Avg: $0.99
  • 52 Week Range: $0.38 - $4.50
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.26
  • P/E Growth: -0.02
Sales & Book Value:
  • Annual Revenue: $14.06 million
  • Price / Sales: 0.31
  • Book Value: $7.19 per share
  • Price / Book: 0.48
Profitability:
  • EBIDTA: ($14,270,000.00)
  • Net Margins: -124.01%
  • Return on Equity: -181.47%
  • Return on Assets: -129.09%
Debt:
  • Current Ratio: 2.29%
  • Quick Ratio: 1.91%
Misc:
  • Average Volume: 180,925 shs.
  • Beta: 0.1
  • Short Ratio: 3.66
 

Frequently Asked Questions for Neurometrix (NASDAQ:NURO)

What is Neurometrix's stock symbol?

Neurometrix trades on the NASDAQ under the ticker symbol "NURO."

When did Neurometrix's stock split? How did Neurometrix's stock split work?

Shares of Neurometrix reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 11th 2017. An investor that had 100 shares of Neurometrix stock prior to the reverse split would have 13 shares after the split.

How were Neurometrix's earnings last quarter?

Neurometrix Inc (NASDAQ:NURO) released its earnings results on Thursday, April, 20th. The company reported ($7.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.92) by $3.36. The business earned $4.31 million during the quarter, compared to analysts' expectations of $4.17 million. Neurometrix had a negative net margin of 124.01% and a negative return on equity of 181.47%. View Neurometrix's Earnings History.

Where is Neurometrix's stock going? Where will Neurometrix's stock price be in 2017?

2 equities research analysts have issued 12-month target prices for Neurometrix's shares. Their predictions range from $36.00 to $36.00. On average, they expect Neurometrix's stock price to reach $36.00 in the next year. View Analyst Ratings for Neurometrix.

Who are some of Neurometrix's key competitors?

Who owns Neurometrix stock?

Neurometrix's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Sabby Management LLC (2.98%). Company insiders that own Neurometrix stock include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Institutional Ownership Trends for Neurometrix.

Who bought Neurometrix stock? Who is buying Neurometrix stock?

Neurometrix's stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC. Company insiders that have bought Neurometrix stock in the last two years include Francis X Mcgillin, Shai Gozani and Thomas T Higgins. View Insider Buying and Selling for Neurometrix.

How do I buy Neurometrix stock?

Shares of Neurometrix can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neurometrix stock cost?

One share of Neurometrix stock can currently be purchased for approximately $3.45.

Analyst Ratings

Consensus Ratings for Neurometrix (NASDAQ:NURO) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $36.00 (943.48% upside)

Analysts' Ratings History for Neurometrix (NASDAQ:NURO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/23/2016HC WainwrightReiterated RatingBuy$36.00N/AView Rating Details
10/21/2016Rodman & RenshawReiterated RatingBuy$36.00N/AView Rating Details
2/29/2016Dawson JamesReiterated RatingBuyN/AView Rating Details
9/11/2015Maxim GroupInitiated CoverageBuy$64.00N/AView Rating Details
(Data available from 5/28/2015 forward)

Earnings

Earnings History for Neurometrix (NASDAQ:NURO)
Earnings by Quarter for Neurometrix (NASDAQ:NURO)
Earnings History by Quarter for Neurometrix (NASDAQ:NURO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/20/2017Q1 2017($3.92)($7.28)$4.17 million$4.31 millionViewN/AView Earnings Details
1/26/2017Q416($6.00)($4.16)$3.48 million$3.70 millionViewListenView Earnings Details
10/20/2016Q316($6.56)($6.08)$3.01 million$3.39 millionViewListenView Earnings Details
7/21/2016Q216($7.44)($42.96)$1.22 million$2.65 millionViewListenView Earnings Details
4/21/2016Q116($7.60)($8.00)$2.65 million$2.28 millionViewListenView Earnings Details
10/22/2015Q315($0.64)($2.08)$6.47 million$2.10 millionViewListenView Earnings Details
7/22/2015Q215($3.84)$9.80 million$1.22 millionViewListenView Earnings Details
2/12/2015Q414($2.88)$4.62 million$1.41 millionViewN/AView Earnings Details
7/24/2014Q413($6.80)$1.16 million$1.34 millionViewN/AView Earnings Details
2/13/2014($6.96)ViewListenView Earnings Details
10/23/2013Q313($2.08)$1.77 million$1.31 millionViewListenView Earnings Details
7/25/2013Q2 2013($7.36)$2.20 million$1.20 millionViewN/AView Earnings Details
2/3/2011($1.36)($1.44)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neurometrix (NASDAQ:NURO)
Current Year EPS Consensus Estimate: $-10.50 EPS
Next Year EPS Consensus Estimate: $-2.73 EPS

Dividends

Dividend History for Neurometrix (NASDAQ:NURO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Neurometrix (NASDAQ:NURO)
Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 6.14%
Insider Trades by Quarter for Neurometrix (NASDAQ:NURO)
Institutional Ownership by Quarter for Neurometrix (NASDAQ:NURO)
Insider Trades by Quarter for Neurometrix (NASDAQ:NURO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2016Shai GozaniCEOBuy3,000$1.31$3,930.00View SEC Filing  
10/28/2016Thomas T HigginsInsiderBuy3,000$1.32$3,960.00View SEC Filing  
10/27/2016Shai GozaniCEOBuy6,000$1.32$7,920.00View SEC Filing  
8/31/2016Thomas T HigginsCFOBuy1,400$1.41$1,974.00View SEC Filing  
8/18/2016Shai GozaniCEOBuy5,000$1.49$7,450.00View SEC Filing  
8/12/2016Thomas T HigginsInsiderBuy2,000$1.45$2,900.00View SEC Filing  
6/1/2016Shai GozaniCEOBuy2,500$1.71$4,275.00View SEC Filing  
5/23/2016Francis X McgillinVPBuy1,000$1.65$1,650.00View SEC Filing  
5/19/2016Shai GozaniCEOBuy12,000$1.55$18,600.00View SEC Filing  
5/19/2016Thomas T HigginsCFOBuy3,200$1.54$4,928.00View SEC Filing  
8/28/2015Thomas T HigginsCFOBuy4,500$0.92$4,140.00View SEC Filing  
8/20/2015Thomas T HigginsCFOBuy5,500$0.91$5,005.00View SEC Filing  
8/11/2015Shai GozaniCEOBuy16,300$0.91$14,833.00View SEC Filing  
11/9/2012Shai GozaniCEOBuy26,800$0.55$14,740.00View SEC Filing  
8/27/2012Krishnamurthy BalachandranCOOBuy5,000$0.67$3,350.00View SEC Filing  
8/21/2012Thomas T HigginsCFOBuy5,000$0.64$3,200.00View SEC Filing  
8/13/2012Krishnamurthy BalachandranCOOBuy5,000$0.70$3,500.00View SEC Filing  
8/8/2012Thomas T HigginsCFOBuy5,000$0.70$3,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Neurometrix (NASDAQ:NURO)
Latest Headlines for Neurometrix (NASDAQ:NURO)
Source:
DateHeadline
finance.yahoo.com logoNeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology
finance.yahoo.com - May 22 at 6:10 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - May 18 at 2:50 PM
finance.yahoo.com logoNeuroMetrix Wins SBANE New England Innovation Award
finance.yahoo.com - May 17 at 6:52 PM
streetinsider.com logoNeuroMetrix (NURO) Says Preliminary Results from Study Evaluating Quell in Chemotherapy-Induced Peripheral Neuropathy to be Presented at APS Meeting
www.streetinsider.com - May 16 at 10:10 AM
finance.yahoo.com logoNeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain
finance.yahoo.com - May 16 at 10:10 AM
finance.yahoo.com logoPreliminary Results from Clinical Study Evaluating Use of Quell in Chemotherapy-Induced Peripheral Neuropathy to be presented at the American Pain Society Annual Meeting
finance.yahoo.com - May 15 at 6:14 PM
streetinsider.com logoNeuroMetrix (NURO) Declares 1-for-8 Reverse Stock Split
www.streetinsider.com - May 13 at 8:20 AM
finance.yahoo.com logoNeuroMetrix Announces One-for-Eight Reverse Split
finance.yahoo.com - May 11 at 7:24 PM
streetinsider.com logoNeuroMetrix (NURO) Announces Expansion of International Intellectual Property Assets for Quell
www.streetinsider.com - May 8 at 6:24 PM
businesswire.com logoNeuroMetrix Reports Substantial Expansion of International Intellectual Property Assets for Quell Wearable Pain Relief Technology
www.businesswire.com - May 8 at 12:15 PM
finance.yahoo.com logoNeuroMetrix Hosts Inaugural Quell User Event
finance.yahoo.com - May 5 at 7:11 PM
americanbankingnews.com logoNeurometrix (NURO) Getting Somewhat Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 3 at 3:24 PM
americanbankingnews.com logoNeurometrix (NURO) Earns Daily News Sentiment Score of 0.04
www.americanbankingnews.com - April 29 at 11:59 AM
americanbankingnews.com logoNeurometrix (NURO) Earning Somewhat Favorable Press Coverage, Analysis Finds
www.americanbankingnews.com - April 26 at 12:28 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Short Interest Update
www.americanbankingnews.com - April 25 at 8:24 PM
americanbankingnews.com logoNeurometrix (NURO) Earns Daily Media Sentiment Score of 0.22
www.americanbankingnews.com - April 21 at 8:08 PM
finance.yahoo.com logoNeuroMetrix, Inc. :NURO-US: Earnings Analysis: Q1, 2017 By the Numbers : April 21, 2017
finance.yahoo.com - April 21 at 6:49 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Releases Earnings Results
www.americanbankingnews.com - April 21 at 1:17 PM
finance.yahoo.com logoEdited Transcript of NURO earnings conference call or presentation 20-Apr-17 12:00pm GMT
finance.yahoo.com - April 21 at 12:00 AM
finance.yahoo.com logoNeuroMetrix Reports Q1 2017 Financial Results
finance.yahoo.com - April 20 at 9:22 AM
finance.yahoo.com logoNeuroMetrix Review Ahead of Thursday's Earnings Call
finance.yahoo.com - April 19 at 10:11 AM
finance.yahoo.com logoNeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond
finance.yahoo.com - April 18 at 6:16 PM
americanbankingnews.com logoSomewhat Positive News Coverage Extremely Likely to Impact Neurometrix (NURO) Share Price
www.americanbankingnews.com - April 18 at 2:52 PM
americanbankingnews.com logoNeurometrix Inc (NURO) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 17 at 9:22 AM
finance.yahoo.com logoNeuroMetrix Named a 50+ Innovation Leader
finance.yahoo.com - April 13 at 6:42 PM
americanbankingnews.com logoFavorable Press Coverage Extremely Likely to Effect Neurometrix (NURO) Stock Price
www.americanbankingnews.com - April 13 at 12:24 PM
businesswire.com logoNeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call - Business Wire (press release)
www.businesswire.com - April 12 at 7:51 PM
finance.yahoo.com logoNeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call
finance.yahoo.com - April 12 at 7:51 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 30 at 9:04 AM
finance.yahoo.com logoNeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting
finance.yahoo.com - March 15 at 7:06 PM
americanbankingnews.com logoNeurometrix Inc (NURO) Upgraded to “Buy” by Zacks Investment Research
www.americanbankingnews.com - March 9 at 1:28 AM
finance.yahoo.com logoNeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017
finance.yahoo.com - March 1 at 7:04 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - February 28 at 6:59 PM
finance.yahoo.com logoNeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy
finance.yahoo.com - February 21 at 5:57 PM
finance.yahoo.com logoNEUROMETRIX, INC. Financials
finance.yahoo.com - February 16 at 6:30 PM
finance.yahoo.com logoNEUROMETRIX, INC. Financials
finance.yahoo.com - February 16 at 6:30 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - February 9 at 7:59 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
biz.yahoo.com - February 8 at 7:51 PM
us.rd.yahoo.com logoNeuroMetrix Reports Q4 and Full Year 2016 Financial Results
us.rd.yahoo.com - January 26 at 11:44 PM
biz.yahoo.com logoQ4 2016 NeuroMetrix Inc Earnings Release - Before Market Open
us.rd.yahoo.com - January 26 at 11:44 PM
biz.yahoo.com logoNEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
us.rd.yahoo.com - January 26 at 11:43 PM
us.rd.yahoo.com logo7:20 am NeuroMetrix reports Q4 results; rev +36% y/y to $3.7 mln
us.rd.yahoo.com - January 26 at 11:43 PM
biz.yahoo.com logoNeuroMetrix Inc Earnings Call scheduled for 8:00 am ET today
biz.yahoo.com - January 26 at 11:43 PM
finance.yahoo.com logoNeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call
finance.yahoo.com - January 20 at 7:44 PM
finance.yahoo.com logo7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately $3.5 mln (+19% Q/Q)
finance.yahoo.com - January 10 at 7:49 PM
seekingalpha.com logoNeuroMetrix says Quell up 19% sequentially in Q4 - Seeking Alpha
seekingalpha.com - January 10 at 8:54 AM
finance.yahoo.com logoNeuroMetrix Reports Strong Quell Demand in Q4 2016
finance.yahoo.com - January 10 at 8:54 AM
publicnow.com logoCES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain
us.rd.yahoo.com - January 3 at 10:13 PM
businesswire.com logoNeuroMetrix to Present at Biotech Showcase 2017 - Business Wire (press release)
www.businesswire.com - January 3 at 5:11 PM
streetinsider.com logoNeuroMetrix (NURO) Enters $7M Private Placement of Preferred ... - StreetInsider.com
www.streetinsider.com - December 28 at 11:49 PM

Social

Chart

Neurometrix (NURO) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by MarketBeat.com Staff